睡眠呼吸暂停手术与非手术治疗的价值:对医疗资源利用的深入审视
该回顾性队列研究基于保险数据库纳入2007年1月至2015年12月诊断为阻塞性睡眠呼吸暂停(OSA)的18至65岁患者,比较手术、持续气道正压通气(CPAP)与未治疗对医疗资源利用的影响。在2年随访中剔除干预成本后,手术组每月总支付、住院、门诊及药品支付均显著低于CPAP组(p < .001)。结论认为手术治疗OSA相比未治疗和CPAP可减少整体医疗资源利用。
要点
- 剔除干预成本后,手术组每月总支付显著低于CPAP组(p < .001)。
- 手术组在住院、门诊及药品支付上均显著低于CPAP组(p < .001)。
- 在所有合并症和年龄组中剔除干预成本后,手术组累计支付低于其他两组。
核心结论
- 相比未治疗和CPAP,手术治疗OSA可减少整体医疗资源利用。
研究设计与样本
- 回顾性队列研究,数据来自基于人群的真实世界保险数据库(IBM Marketscan Research数据库)。
- 纳入2007年1月至2015年12月诊断为OSA的18至65岁患者,共4,978,649名参与者,均有至少25个月连续参保。
- 排除既往因非OSA适应症行软组织手术(鼻部手术)或保险覆盖不连续的患者。
- 18,050例接受手术,1,054,578例未治疗,799,370例接受CPAP。
- 数据收集跨越2年,生成预测模型评估随时间变化的趋势。
主要发现
- 在2年随访中剔除干预成本后,手术组(第1组)每月总支付、住院支付、门诊支付及药品支付均显著低于CPAP组(第3组)(p < .001)。
- 在所有合并症和年龄组中剔除干预成本(CPAP或手术)后,手术组累计支付低于其他两组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine how surgery, continuous positive airway pressure (CPAP), and no treatment impact health care utilization in patients who have obstructive sleep apnea (OSA). STUDY DESIGN: This is a retrospective cohort study of patients between the ages of 18 and 65 that were diagnosed with OSA (9th International Classification of Diseases) from January 2007 to December 2015. Data were collected over 2 years, and prediction models were generated to evaluate trends over time. SETTING: A population-based study using real-world data and insurance databases. METHODS: A total of 4,978,649 participants were identified, all with at least 25 months of continuous enrollment. Patients with previous soft tissue procedures not approved for OSA (nasal surgery), or without continuous insurance coverage were excluded. A total of 18,050 patients underwent surgery, 1,054,578 were untreated, and 799,370 received CPAP. IBM Marketscan Research database was utilized to describe patient-specific clinical utilization, and expenditures, across outpatient, and inpatient services, and medication prescriptions. RESULTS: When the cost of the intervention was eliminated in the 2-year follow-up, the monthly payments of group 1 (surgery) were significantly less than group 3 (CPAP) in overall, inpatient, outpatient, and pharmaceutical payments (p < .001). The surgery group was associated with less cumulative payments compared to the other 2 groups when the cost of the intervention (CPAP or surgery) was eliminated in all comorbidities and age groups. CONCLUSION: Treating OSA with surgery can lessen overall health care utilization compared to no treatment and CPAP.
引用
- Abdelwahab M, Marques S, Huang A, et al. Value of Surgical and Nonsurgical Treatment for Sleep Apnea: A Closer Look at Health Care Utilization. Otolaryngol Head Neck Surg. 2023. PMID: 36794772. doi:10.1002/ohn.175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。